Latest News and Press Releases
Want to stay updated on the latest news?
-
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
-
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases to launch its first clinical trial of EVerGel™ in 2026.